Skip to main content
. 2023 Aug 28;6(8):e2331197. doi: 10.1001/jamanetworkopen.2023.31197

Figure 1. Distribution of CA19-9 and Bilirubin Serum Levels in the Development and Validation Cohorts.

Figure 1.

Side-by-side box-and-violin plot of CA19-9 and bilirubin serum levels in the development and validation cohort for PDAC (blue) and benign disease (orange). CA19-9 refers to carbohydrate antigen 19-9 and PDAC, to pancreatic ductal adenocarcinoma.